Loading
Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹1.9 LQualified Make: NA
Model: Antispasmodic Tab containing Mefenamic Acid 250 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 905 LODHA SUPREMUS OPP LODHA WORLD TOWER SENAPATI BAPAT MARG LOWER PAREL WEST MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | Make: NA
Model: Antispasmodic Tab containing Mefenamic Acid 250 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | ₹1.9 L | L1 | Qualified MII |
| 2 | L2₹1.9 L+₹3,500 (1.89%)Qualified Make: Unbranded--JACKSON LABORATORIES PRIVATE LIMITED
Model: Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | Make: Unbranded--JACKSON LABORATORIES PRIVATE LIMITED
Model: Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | ₹1.9 L+₹3,500 (1.89%) | L2 | Qualified MII |
| 3 | L3₹2.1 L+₹21,000 (11.3%)Qualified Make: NA
Model: Monispas
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 F 29 4 2ND FLOOR OKHLA INDUSTRIAL AREA PHASE II SOUTH DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Make: NA
Model: Monispas
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | ₹2.1 L+₹21,000 (11.3%) | L3 | Qualified MII |
| 4 | Disqualified Make: NA
Model: Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg TAB
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | Make: NA
Model: Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg TAB
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | - | - | Disqualified MSE, MII, Category: General |
| 5 | Disqualified Make: Unbrand
Model: Antispasmodic Tab containing Mefenamic Acid 250 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 SHOP NO 27 GR FLR BIZZBAY S NO 29 1 1 2 3 29 2 TO 6 PROP NO O E 01 03100069 NIBM ROAD KONDHAWA KHURD PUNE MAHARASHTRA 411048 UDYAM MH 26 0741951 | PUNE | MAHARASHTRA | 411048 | Make: Unbrand
Model: Antispasmodic Tab containing Mefenamic Acid 250 mg
Title: Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622 | - | - | Disqualified MII |
Tender Value
Refer Docs
EMD Value
₹10,600
Closing Date
22 Jun 2026, 4:00 pmClosed
Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg
PVMS No 011622
9420379
GEM/2026/B/7621538
Two Packet Bid
Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg, PVMS No 011622
Mumbai, Maharashtra
Total value wise evaluation
PRODUCT_CUSTOM
11 documents required · 11 mandatory
3 yrs
₹2 L
₹20 L
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Antispasmodic Tab containing Mefenamic Acid 250 mg & Dicyclomine HCl 10 mg | - | - | - |
| PVMS No 011622 | - | - | - |
The Commandant AFMSD Mumbai, Afmsd Mumbai, Department of Defence, DG Armed Forces Medical Service, Ministry of Defence, Akurli Cross Road, No. 03 Kandivali East, Mumbai, Maharashtra- 400 101, (The President Of India, Through Commandant Afmsd Mumbai)
₹10,600
31 Aug 2026
12 Jun 2026
22 Jun 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9420379.pdf
GEM_BID • 0.12 MB
011622_2026-06-04-12-09-03_16b2ce15ff1ac123e1dbdb19bd16c007.pdf
GEM_SPEC • 0.33 MB
011622_51f3a337-f78a-46b7-8a6e1781258882110_afmsdmumbailpo.docx
GEM_OTHER • 0.03 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .